SCHEMBL425590

SCHEMBL425590

CCCCCCCCCCCCCCC(CC(O)CO)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 2/20 0.62
GRIK2 Q13002 2/20 0.62
SLC1A2 P43004 2/20 0.59
SLC1A1 P43005 2/20 0.59
GPR84 Q9NQS5 7/20 0.53
FFAR1 O14842 2/20 0.53
SLC1A3 P43003 1/20 0.51
CA2 P00918 2/20 0.50
MAPK1 P28482 1/20 0.50
FFAR4 Q5NUL3 1/20 0.49
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
PPARD Q03181 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
ACE2 Q9BYF1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28996904 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL168065 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL167223 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
Dodecane SCHEMBL1325927 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL1237976 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL23854065 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL165538 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL17646228 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL1512830 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84
SCHEMBL4962689 1.00 GRIK1 (0.62) GRIK1GRIK2SLC1A2SLC1A1GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4119124-B1 MICROEMULSION CONTAINING ORALLY DISINTEGRATING FILM COMPOSITIONS WITH ADJUSTABLE PHYSICAL AND RHEOLOGICAL PROPERTIES VEKTOR PHARMA TF GMBH (DE) 2025-10-01 EP claimed
EP-4129270-B1 MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS APPLIED PHARMA RES (CH) 2024-09-11 EP claimed
EP-4114182-A1 METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS Apeel Technology, Inc. (US) 2023-01-11 EP claimed
EP-3355856-B1 MODIFIED RELEASE ORALLY ADMINISTERED AMINO ACID FORMULATIONS APPLIED PHARMA RES (CH) 2022-06-22 EP claimed
US-20210298298-A1 METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS APEEL TECHNOLOGY, INC. 2021-09-30 US claimed
WO-2021058158-A1 PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ETHOXYLATED FATTY ACID ESTER HENKEL AG & CO. KGAA (DE) 2021-04-01 WO claimed
EP-3210474-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING POLYPEPTIDES AND RELATED METHODS OF DELIVERY CHIASMA INC (US) 2020-11-18 EP claimed
EP-3237067-B1 ODOR-REDUCING DEVELOPER FOR OXIDATION DYES HENKEL AG & CO KGAA (DE) 2019-10-23 EP claimed
EP-2488018-B1 METHODS AND COMPOSITIONS FOR NOVEL LIQUID CRYSTAL DELIVERY SYSTEMS COPPERHEAD CHEMICAL COMPANY (US) 2019-05-22 EP claimed
EP-3233035-B1 THICKENING DEVELOPER FOR OXIDATION PRODUCTS HENKEL AG & CO KGAA (DE) 2019-05-01 EP claimed
EP-0919219-B1 Means for increasing formability and gloss of hairs WELLA AG (DE) 2004-08-11 EP claimed
EP-0754031-B1 MULTILAMELLAR DRUG DELIVERY SYSTEMS SHIRE LAB INC (US) 2004-03-24 EP claimed
EP-0750494-B1 HYDROPHOBIC DRUG DELIVERY SYSTEMS SHIRE LAB INC (US) 2003-10-15 EP claimed
EP-0971750-B1 ABSORBENT ARTICLES HAVING LOTIONED LEG CUFFS PROCTER & GAMBLE (US) 2003-02-26 EP claimed
EP-0734474-B1 LOTION COMPOSITION FOR TISSUE PAPER PROCTER & GAMBLE (US) 2002-06-05 EP claimed
EP-1055407-A2 Hair styling oil Wella Aktiengesellschaft (DE) 2000-11-29 EP claimed
EP-0919219-A2 Means for increasing formability and gloss of hairs Wella Aktiengesellschaft (DE) 1999-06-02 EP claimed
EP-0369992-B1 Toilet bowl cleaner KIWI BRANDS INC (US) 1995-01-18 EP claimed
EP-0238302-B1 SKIN TREATMENT COMPOSITION Richardson-Vicks, Inc. (US) 1992-05-27 EP claimed
EP-0250268-B1 TOILET BOWL CLEANER KIWI BRANDS INC (US) 1990-12-05 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210298298-A1 METHODS AND COMPOSITIONS FOR IMPROVING THE PROPERTIES AND PRODUCTIVITY OF PLANTS MGLL, AGL, GK GRIK1 1110/4885GRIK2 1070/4885SLC1A2 4785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.